معرفی
Ming Zhao is an Assistant Professor in the Department of Pharmaceutical Chemistry at the University of Kansas School of Pharmacy. His research focuses on developing advanced materials and systems for biomedical applications, particularly at the interface of functional materials and biology. He holds a Ph.D. in Chemical Engineering from the University of California, Los Angeles, and completed postdoctoral training at MIT and Harvard Medical School.
- Education:
- Ph.D., Chemical Engineering, UCLA (2018)
- M.S., Biochemistry, Zhejiang University (2013)
- B.S., Bioengineering, Zhengzhou University (2010)
Research interests include non-viral CRISPR delivery systems, oral protein delivery platforms for metabolic diseases, and bioelectrochemical sensors for in vivo diagnostics. His lab innovates nanotechnology-based solutions for precision medicine and real-time biomarker monitoring. Recent work addresses challenges in gene editing safety, gastrointestinal drug retention, and multiplexed biomolecule patterning on microelectrode arrays.
Publications span high-impact journals like Nano Today, Analyst, and WIREs Nanomedicine, with a focus on translating engineering principles into clinical applications. Notable projects include CRISPR-Cas9 RNP delivery systems and gastric-resident microdevices for sustained protein release.
Led the development of novel zwitterionic polymers reducing immunogenicity in drug delivery. Active in interdisciplinary collaborations across mechanical engineering, materials science, and clinical medicine.
